Spinal cord stimulation for the treatment of central pain in Multiple Sclerosis

ISRCTN ISRCTN36818685
DOI https://doi.org/10.1186/ISRCTN36818685
Secondary identifying numbers 4891
Submission date
23/04/2010
Registration date
23/04/2010
Last edited
24/01/2018
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nervous System Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Ms K Maciver
Scientific

Pain Research Institute
Clinical Sciences Centre
Fazakerley Hospital
Lower Lane
Liverpool
L9 7AL
United Kingdom

Study information

Study designNon-randomised interventional treatment trial
Primary study designInterventional
Secondary study designNon randomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleComparison of spinal cord stimulation and the clinical and quantitative sensory testing response in patients with MS pain versus patients with peripheral nerve injury pain
Study objectivesWe are measuring the effect of spinal cord stimulation on central pain in Multiple Sclerosis (MS), comparing the clinical and Quantitative Sensory Testing response in patients with MS pain and those with peripheral nerve injury pain. We hypothesise that MS pain patients will have a different sensory profile to peripheral nerve injury pain patients. We also hypothesise that spinal cord stimulation will benefit most of the peripheral nerve injury patients and some of the MS pain patients. We are collecting Quantitative Sensory Testing measurements from an age- and gender-matched group of healthy volunteers.
Ethics approval(s)South Sefton LREC, 08/08/2008, ref: 08/H1001/103
Health condition(s) or problem(s) studiedTopic: Neurological; Subtopic: Neurological (all Subtopics); Disease: Nervous system disorders
InterventionTrial of spinal cord stimulation. A temporary electrode is inserted into the eipdural space and attached to an external radiofrequency transmitter, which when switched on gives a pleasant paraesthesia in the area of pain. This stimulator remains in situ for 7 days. Pain diaries are kept throughout the trial and Quantitative Sensory Testing is completed once with stimulation and once without, with the tester blinded.

Follow up length: 2 months
Intervention typeOther
Primary outcome measureChanges in pain scores measured by daily pain diaries, measured on day 7 of the trial
Secondary outcome measuresComparison of QST measurements in MS patients with and without stimulation, measured on day 5 of the trial, when the second sensory testing is complete
Overall study start date01/07/2008
Completion date30/06/2010

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participantsPlanned Sample Size: 302) MS central neuropathic pain3) Peripheral nerve injury pain
Key inclusion criteria1. Group 1: Confirmed MS with central pain
2. Group 2: Peripheral nerve injury pain
3. Both groups eligible for spinal cord stimulation
4. Group 3: Age- and gender-matched healthy controls
5. Male and female, aged 18 years or older
Key exclusion criteria1. Unsuitable for spinal cord stimulation
2. High intake of opiates
3. High levels of psychological distress
Date of first enrolment01/07/2008
Date of final enrolment30/06/2010

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Pain Research Institute
Liverpool
L9 7AL
United Kingdom

Sponsor information

Walton Centre for Neurology and Neurosurgery (UK)
Hospital/treatment centre

Division of Neurological Science
Clinical Sciences Centre for Research and Education
Lower Lane
Liverpool
L9 7LJ
England
United Kingdom

Website http://www.thewaltoncentre.nhs.uk/
ROR logo "ROR" https://ror.org/05cvxat96

Funders

Funder type

Charity

Multiple Sclerosis Society (UK)
Private sector organisation / Associations and societies (private and public)
Alternative name(s)
Multiple Sclerosis Society of Great Britain and Northern Ireland, The MS Society, MS Society UK, Multiple Sclerosis Society UK, MS Society
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Editorial Notes

24/01/2018: No publications found in PubMed, verifying study status with principal investigator.